HealthTree Logo
search more_vert
close
person Sign In / Create Account
An Incredible Year for Multiple Myeloma. Highlights with Dr. Robert Orlowski, MD, PhD, MD Anderson
An Incredible Year for Multiple Myeloma. Highlights with Dr. Robert Orlowski, MD, PhD, MD Anderson image
HealthTree Podcast for Multiple Myeloma
event Dec 18, 2015 / 11:00AM MST

Event Description

Dr. Robert Orlowski, MD, PhD MD Anderson Cancer Center Interview Date: December 18, 2015 

This will be remembered as a banner year for multiple myeloma with the introduction of 5 new FDA-approved drugs. Dr. Orlowski gives us his take on the year with a "Top 12" from the December ASH conference in Orlando. His top picks include both clinical studies looking at combinations of different current drugs, the newly approved drugs, and beginnings of using immunotherapies in clinical practice. Learn more about the new announcements with an easy-to-understand but deep perspective from a multiple myeloma expert. 

multiple myeloma 

Thanks to our episode sponsor, Amgen

Schedule & Agenda

person
Discussion
11:00AM
Dr. Robert Orlowski & Jenny Ahlstrom

Speakers & Moderators

The panelist Robert Orlowski, MD, PhD
Robert Orlowski, MD, PhD

Robert Z. Orlowski, M.D., Ph.D., is Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics, where he is board-certified in medical oncology. Dr. Orlowski earned his doctoral degree in molecular biophysics and biochemistry from Yale University and his medical degree from the Yale University School of Medicine. He completed his internship and residency in Internal Medicine at Barnes Hospital at the Washington University in St. Louis School of Medicine. After his fellowships in Hematology and Medical Oncology at John Hopkins Sidney Kimmel Comprehensive Cancer Center, he joined the faculty at University of North Carolina in Chapel Hill. Following that, Dr. Orlowski accepted a position at The University of Texas MD Anderson Cancer Center in 2007 to lead the Myeloma Section in the Department of Lymphoma/Myeloma. His research interests include pathobiology of, novel therapeutic targets and mechanisms of drug resistance in myeloma which are documented in hundreds of scientific articles, book chapters, and presentations at conferences. Dr. Orlowski is an investigator on numerous clinical trials, and appointed Myeloma Committee Chair for SWOG.

Read Bio
The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube